tiprankstipranks
Trending News
More News >
CytoDyn (CYDY)
OTHER OTC:CYDY
US Market
Advertisement

CytoDyn (CYDY) Income Statement

Compare
682 Followers

CytoDyn Income Statement

Last quarter (Q1 2026), CytoDyn's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, CytoDyn's net income was $-5.54M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ -5.92M$ 0.00$ 0.00$ 266.00K$ 0.00
Gross Profit
$ -18.00K$ -29.00K$ -175.00K$ 213.00K$ -1.80M
Operating Expenses
$ -11.34M$ 18.06M$ 40.40M$ 72.13M$ 92.75M
Depreciation and Amortization
$ 18.00K$ 29.00K$ 175.00K$ 781.00K$ 1.80M
EBITDA
$ 8.62M$ -18.03M$ -40.40M$ -194.97M$ -92.75M
Operating Income
$ 11.32M$ -18.06M$ -40.58M$ -145.40M$ -104.60M
Other Income/Expenses
$ 0.00$ -31.78M$ -39.25M$ -65.42M$ -50.08M
Pretax Income
$ 3.75M$ -49.84M$ -79.82M$ -210.82M$ -154.67M
Net Income
$ 3.75M$ -49.84M$ -79.82M$ -210.82M$ -174.02M
Per Share Metrics
Basic EPS
$ 0.00$ -0.05$ -0.10$ -0.43$ -0.30
Diluted EPS
$ 0.00$ -0.05$ -0.10$ -0.43$ -0.30
Weighted Average Shares Outstanding
1.21B 969.51M 836.53M 676.90M 587.59M
Weighted Average Shares Outstanding (Diluted)
1.24B 969.51M 836.53M 676.90M 587.59M
Currency in USD

CytoDyn Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis